1. Editor's page

   EditorialNotes Pages: S1 - S1

2. Symposium introduction and overview adjuvant therapy of breast cancer: Perspectives for the '80s

   • Joseph Allegra

   EditorialNotes Pages: S3 - S5

3. Treatment of primary breast cancer with L-PAM/5-FU and tamoxifen: An interim report

   • Bernard Fisher
   • other NSABP investigators

   EditorialNotes Pages: S7 - S17

4. Adjuvant chemotherapy in stage-II breast cancer: An overview of the NSABP clinical trials

   • Norman Wolmark
   • Bernard Fisher
   • contributing NSABP investigators

   EditorialNotes Pages: S19 - S26

5. Adjuvant therapy of breast cancer: The Southwest Oncology Group experience

   • William A. Knight III
   • Saul E. Rivkin
   • Robert M. O'Bryan

   EditorialNotes Pages: S27 - S33

6. Multiple trials of adjuvant chemohormonal therapy in the treatment of breast cancer: Preliminary results—the ECOG experience

   • P. P. Carbone

   EditorialNotes Pages: S35 - S38

7. Cancer and Leukemia Group B adjuvant chemotherapy trials in postmastectomy breast cancer patients

   • William C. Wood
   • CALGB

   EditorialNotes Pages: S39 - S43

8. Ovarian irradiation and prednisone following surgery and radiotherapy for carcinoma of the breast

   • J. W. Meakin
   • W. E. C. Allt
   • R. D. Bulbrook

   EditorialNotes Pages: S45 - S48

9. Postmastectomy adjuvant chemotherapy with or without radiation therapy in women with operable breast cancer and positive axillary lymph nodes: The Southeastern Cancer Study Group experience

   • Enrique Velez-Garcia
   • Melvin Moore
   • Richard Smalley

   EditorialNotes Pages: S49 - S60

10. Adjuvant endocrine therapy, cytotoxic chemotherapy, and immunotherapy in stage-II breast cancer: Five-year results

    • Olof H. Pearson
    • Charles A. Hubay
    • 24 participating investigators

    EditorialNotes Pages: S61 - S68

11. Prognostic factors in primary breast cancer

    • Gary M. Clark
    • William L. McGuire

    EditorialNotes Pages: S69 - S72

12. Laboratory studies to develop general principles for the adjuvant treatment of breast cancer with antiestrogens: Problems and potential for future clinical applications

    • V. Craig Jordan
    • C. Chem

    EditorialNotes Pages: S73 - S86